LivaNova PLC (LIVN)
Health Care / Health Care Equipment
S&P MidCap 400$64.62
Middle of the pack. No strong signal either way.
Consider Buy
Score based on 4 of 5 models — moderate confidence
Is LivaNova PLC a Good Investment in 2026?
LivaNova PLC (LIVN) scores 6.4 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Lynch model rates LivaNova PLC as Strong. The Graham model is the least favorable, rating it Neutral. LivaNova PLC currently trades above its estimated fair value of $63, suggesting limited upside at current prices. LivaNova PLC ranks #193 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading near estimated fair value.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
5/9
Buffett
Neutral
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Strong
Growth rate vs price (PEG)
Greenblatt
Strong
Top 25% (rank 16%)
Frequently Asked Questions
Is LivaNova PLC (LIVN) a good investment?
What is LivaNova PLC's Piotroski F-Score?
Is LIVN overvalued or undervalued?
How does LIVN compare to other Health Care stocks?
What do investment models say about LIVN?
Similar Stocks
Compare LIVN with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer